Cardioprotective effect of l-glutamate in obese type 2 diabetic zucker fatty rats

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 9, 2009, Pages 892-898

  Povlsen, J A ^a   Lofgren B ^a   Rasmussen, L E ^a   Nielsen, J M ^a   Norregaard R ^b   Kristiansen, S B ^a   Botker H E ^a   Nielsen, T T ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Diabetes mellitus; Excitatory amino acid transporters; Ischaemia; L glutamate; Myocardial infarction; Reperfusion

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 3; GLUTAMIC ACID; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; HEART INFARCTION SIZE; HEART MUSCLE FIBER MEMBRANE; HEART PROTECTION; HYPOTHESIS; IMMUNOBLOTTING; IN VIVO STUDY; ISOLATED HEART; MALE; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN EXPRESSION; RAT; REPERFUSION;

ANIMALS; BLOTTING, WESTERN; CARDIOTONIC AGENTS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 3; GLUTAMIC ACID; HEMODYNAMICS; MALE; MITOCHONDRIA, HEART; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OBESITY; PERFUSION; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED WKY; RATS, ZUCKER; RNA, MESSENGER; SARCOLEMMA; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 69949086741     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05166.x     Document Type: Article

References (31)

1. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 1998 339 : 229 234.
2. Kristiansen SB, Lofgren B, Stottrup NB et al. Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes. Diabetologia 2004 47 : 1716 1721.
3. Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM. Preconditioning the diabetic heart: The importance of Akt phosphorylation. Diabetes 2005 54 : 2360 2364.
4. Stottrup NB, Kristiansen SB, Lofgren B et al. l-Glutamate and glutamine improve haemodynamic function and restore myocardial glycogen content during postischaemic reperfusion: A radioactive tracer study in the rat isolated heart. Clin. Exp. Pharmacol. Physiol. 2006 33 : 1099 1103.
5. Pisarenko OI, Lepilin MG, Ivanov VE. Cardiac metabolism and performance during l-glutamic acid infusion in postoperative cardiac failure. Clin. Sci. 1986 70 : 7 12.
6. Svedjeholm R, Vanhanen I, Hakanson E, Joachimsson PO, Jorfeldt L, Nilsson L. Metabolic and hemodynamic effects of intravenous glutamate infusion early after coronary operations. J. Thorac. Cardiovasc. Surg. 1996 112 : 1468 1477.
7. Kristiansen SB, Lofgren B, Stottrup NB et al. Cardioprotection by l-glutamate during postischaemic reperfusion: Reduced infarct size and enhanced glycogen resynthesis in a rat insulin-free heart model. Clin. Exp. Pharmacol. Physiol. 2008 35 : 884 888.
8. Safer B. The metabolic significance of the malate-aspartate cycle in heart. Circ. Res. 1975 37 : 527 533.
9. Pisarenko OI, Solomatina ES, Studneva IM, Ivanov VE, Kapelko VI, Smirnov VN. Effect of glutamic and aspartic acids on adenine nucleotides, nitrogenous compounds and contractile function during underperfusion of isolated rat heart. J. Mol. Cell. Cardiol. 1983 15 : 53 60.
10. Bradamante S, Marchesani A, Barenghi L, Paracchini L, de Jonge R, de Jong RW. Glycogen turnover and anaplerosis in preconditioned rat hearts. Biochim. Biophys. Acta 2000 1502 : 363 379.
11. Thomassen AR, Nielsen TT, Bagger JP, Henningsen P. Myocardial exchanges of glutamate, alanine and citrate in controls and patients with coronary artery disease. Clin. Sci. 1983 64 : 33 40.
12. Wang P, Chatham JC. Onset of diabetes in Zucker diabetic fatty (ZDF) rats leads to improved recovery of function after ischemia in the isolated perfused heart. Am. J. Physiol. Endocrinol. Metab. 2004 286 : E725 36.
13. Thomassen AR, Bagger JP, Nielsen TT et al. Altered global myocardial substrate preference at rest and during pacing in coronary artery disease with stable angina pectoris. Am. J. Cardiol. 1988 62 : 686 693.
14. Kimose HH, Ravkilde J, Helligso P et al. Myocardial loss of glutamate after cold chemical cardioplegia and storage in isolated blood-perfused pig hearts. Thorac. Cardiovasc. Surg. 1993 41 : 93 100.
15. Backstrom T, Goiny M, Lockowandt U, Liska J, Franco-Cereceda A. Cardiac outflow of amino acids and purines during myocardial ischemia and reperfusion. J. Appl. Physiol. 2003 94 : 1122 1128.
16. Pereda D, Castella M, Pomar JL et al. Elective cardiac surgery using Celsior or St. Thomas 2 solution: A prospective, single-center, randomized pilot study. Eur. J. Cardiothorac. Surg. 2007 32 : 501 506.
17. Dinkelborg LM, Kinne RK, Grieshaber MK. Transport and metabolism of l-glutamate during oxygenation, anoxia, and reoxygenation of rat cardiac myocytes. Am. J. Physiol. 1996 270 : H1825 32.
18. Ralphe JC, Segar JL, Schutte BC, Scholz TD. Localization and function of the brain excitatory amino acid transporter type 1 in cardiac mitochondria. J. Mol. Cell. Cardiol. 2004 37 : 33 41.
19. King N, Williams H, McGivan JD, Suleiman MS. Characteristics of l-aspartate transport and expression of EAAC-1 in sarcolemmal vesicles and isolated cells from rat heart. Cardiovasc. Res. 2001 52 : 84 94.
20. Kugler P. Expression of glutamate transporters in rat cardiomyocytes and their localization in the T-tubular system. J. Histochem. Cytochem. 2004 52 : 1385 1392.
21. 1 protein expression in hyper- and hypothyroidism. Am. J. Physiol. Heart Circ. Physiol. 2005 288 : H2521 6.
22. Palmieri F. The mitochondrial transporter family (SLC25): Physiological and pathological implications. Pflügers Arch. 2004 447 : 689 709.
23. Feldkamp T, Kribben A, Roeser NF, Ostrowski T, Weinberg JM. Alleviation of fatty acid and hypoxia-reoxygenation-induced proximal tubule deenergization by ADP/ATP carrier inhibition and glutamate. Am. J. Physiol. Renal Physiol. 2007 292 : F1606 16.
24. Pisarenko OI. Mechanisms of myocardial protection by amino acids: Facts and hypotheses. Clin. Exp. Pharmacol. Physiol. 1996 23 : 627 633.
25. Weinberg JM, Venkatachalam MA, Roeser NF, Nissim I. Mitochondrial dysfunction during hypoxia/reoxygenation and its correction by anaerobic metabolism of citric acid cycle intermediates. Proc. Natl Acad. Sci. USA 2000 97 : 2826 2831.
26. Comte B, Vincent G, Bouchard B, Benderdour M, Des Rosiers C. Reverse flux through cardiac NADP(+)-isocitrate dehydrogenase under normoxia and ischemia. Am. J. Physiol. Heart Circ. Physiol. 2002 283 : H1505 14.
27. Vogt AM, Poolman M, Ackermann C et al. Regulation of glycolytic flux in ischemic preconditioning. A study employing metabolic control analysis. J. Biol. Chem. 2002 277 : 24 411 19.
28. Gonzalez-Mateos F, Gomez ME, Garcia-Salguero L, Sanchez V, Aragon JJ. Inhibition of glycolysis by amino acids in ascites tumor cells. Specificity and mechanism. J. Biol. Chem. 1993 268 : 7809 7817.
29. King N, McGivan JD, Griffiths EJ, Halestrap AP, Suleiman MS. Glutamate loading protects freshly isolated and perfused adult cardiomyocytes against intracellular ROS generation. J. Mol. Cell. Cardiol. 2003 35 : 975 984.
30. Lowell BB, Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 2005 307 : 384 387.
31. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev. 2008 88 : 581 609.